MedPath

An observational study to see whether Neurodevelopmental outcome is affected at 18-24 months of age in Neonates with Mild HIE and borderline low Apgar without therapeutic hypothermia

Not Applicable
Conditions
Health Condition 1: P00-P04- Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery
Registration Number
CTRI/2020/01/022958
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other (Terminated)
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Babies with mild hypoxic Ischaemic Encephalopathy(HIE)/HIE stage I/ Apgar score of 5 to 7 at 5 mins those who have not received therapeutic hypothermia

Exclusion Criteria

HIE stage I or mild HIE/Apgar 5 to 7 at 5 mins those who received therapeutic hypothermia

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath